Highlights • Cure rates are high for choriocarcinoma, however chemoresistant disease often leads to death.• High expression of PD-L1 suggests a role for checkpoint inhibitors in choriocarcinoma.• Pembrolizumab should be… Click to show full abstract
Highlights • Cure rates are high for choriocarcinoma, however chemoresistant disease often leads to death.• High expression of PD-L1 suggests a role for checkpoint inhibitors in choriocarcinoma.• Pembrolizumab should be considered for salvage therapy for chemoresistant choriocarcinoma.
               
Click one of the above tabs to view related content.